• 2024 Foundational Training Pacesetter Award winner

• Develop and deepen strategic partnerships with C-suite executives and key population health decision makers within top community and health system/IDN accounts (Northwell, NYU Langone)• Support clinical advocacy by gaining KOL endorsement to ensure coverage via contracted pharmacy pathways• Negotiate preferred pharmacy provider contracts and educate for pull through of implementation processes• Ranked #1 nationally for 2023, $3,365,756 net sales• Ranked #1 Q1 2024 for New Prescribers• Continuously lead nation with Preferred Pharmacy contract wins

● Demonstrate driven sales and partnerships success by independently prioritizing and managing full sales cycle from lead generation to account maintenance● Implement SaaS digital solutions (AltoConnect®) and integrate practice EMR’s to streamline prior authorizations, clinical clarifications and therapeutic substitutions● Create and present Client Success Dashboard to drive user-level metrics, including activation, engagement, product adoption and net promoter scores● Continually creating an advocacy network of drug manufacturer and device representatives through pharmacy offerings and solutions● Competent in buy and bill and specialty pharmacy supply chain, including relevant medical and pharmaceutical benefit reimbursement process● Nationally ranked top 5%, maintained 146% to goal 2022● Regional Core Value Award winner

Obesity Care Specialist• Launched the first and only once weekly injectable GLP-1 Wegovy® for Chronic Weight Management • Launched first in class GLP-1 Saxenda® Injectable daily therapy for Long Term Chronic Weight management• Grew Long Island Territory from $0 to $1.5 MM in sales in a five year period• 20% Volume Contribution to NY Metro MSA (Top 3 Volume Obesity Market in the U.S.)• Expert level understanding of Chronic Weight Management Market development as an office based Medical specialty practice• Subject Matter Expert understanding of specialty pharmacy high touch service for high cost Bio-Pharma Therapies• Expert level understanding of Diagnostic and Therapeutic treatment codes for Obesity Medical Management and Bariatric Surgery• Consistent 50% volume growth, YoY for Saxenda® since launch in 2015 outpacing Brand Anti-Obesity Market (BAOM) competitors• Market Development to include Eco-system approach of Health System, Public Policy, Health Legislation, Payer Value Proposition, Employer, and Patient Advocacy on burden of disease and Health Economic of Chronic Obesity• Account lead to collaborative planning with internal stakeholders to include Market Access, Medical, Marketing, Government Affairs, Educator, and Agency partners• KOL management of Medical and Surgical HCP(s) to expand Chronic Obesity Market to retail and non-retail accounts• Total Dirt territory management model, Single Sales Person, inclusive of Retail-Office Based HCP, Non-Retail Health System, Pharmacy, Employer, and Local-Municipal call plan targets• Multiple awards for Performance, Leadership, and StrategyDiabetes Care Specialist• Responsible for sale and promotion of NNI Injectable anti-diabetic therapies (GLP-1 and Insulin Portfolio)• Full scale promotional responsibility for Office based specialties treating Type I/II Diabetes Mellitus• Promoted to Obesity Specialty Team for launch of novel GLP-1 Saxenda® for treatment of Chronic Obesity

• Business to Business Sales role responsible for selling ad space to targeted colligate and professional sports programs.• Negotiated ad buys with C-level professionals on ad/rate/penetration and ROI for customized purchase packages• Worked to construct promotional pull through events with advertisers and purchasing collegiate/professional sports organizations• Exceeded all performance metrics